| May-14-19 11:55PM | Edited Transcript of RVNC earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents |
| 04:05PM | Revance to Participate in the RBC Capital Markets 2019 Healthcare Conference Business Wire |
| May-09-19 10:23AM | Revance Therapeutics (RVNC) Q1 2019 Earnings Call Transcript Motley Fool |
| May-08-19 04:05PM | Revance Reports First Quarter 2019 Financial Results and Provides Corporate Update Business Wire |
| May-07-19 12:51PM | Is Revance Therapeutics Inc (RVNC) A Good Stock To Buy? Insider Monkey |
| May-01-19 02:21PM | A Spotlight On Revance Therapeutics, Inc.'s (NASDAQ:RVNC) Fundamentals Simply Wall St. |
| 10:32AM | Will Revance Therapeutics (RVNC) Report Negative Earnings Next Week? What You Should Know Zacks |
| Apr-24-19 04:05PM | Revance to Release First Quarter 2019 Financial Results on Wednesday, May 8, 2019 Business Wire |
| Apr-09-19 08:00AM | Revance Appoints Former Allergan Marketing Veteran Taryn Conway as Vice President of Marketing Business Wire |
| Apr-08-19 04:05PM | SAKURA 3 Trial Results Presented on Podium at Worlds Largest Medical Aesthetic Conference Business Wire |
| Apr-04-19 05:46PM | Maker of Botox alternative turns toxin on crippling muscle disorder American City Business Journals |
| Apr-02-19 04:05PM | Revance to Participate in the Needham Healthcare Conference Business Wire |
| Apr-01-19 01:48PM | Does Revance Therapeutics, Inc. (NASDAQ:RVNC) Have A Volatile Share Price? Simply Wall St. |
| 07:15AM | New Research: Key Drivers of Growth for Fresh Del Monte Produce, Baker Hughes, a GE company, HollyFrontier, Glaukos, HCI Group, and Revance Therapeutics Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire |
| Mar-05-19 04:05PM | Revance to Participate in Upcoming Investor Conferences Business Wire |
| Mar-01-19 10:18AM | Edited Transcript of RVNC earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents |
| 05:48AM | Revance Therapeutics Inc (RVNC) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com |
| Feb-28-19 08:08AM | Need To Know: Revance Therapeutics, Inc. (NASDAQ:RVNC) Insiders Have Been Buying Shares Simply Wall St. |
| Feb-26-19 08:00PM | Revance Therapeutics Inc (RVNC) Q4 2018 Earnings Conference Call Transcript Motley Fool |
| 04:05PM | Revance Releases Fourth Quarter and Full Year 2018 Results Business Wire |
| Feb-12-19 04:05PM | Revance to Release Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 26, 2019 Business Wire |
| Feb-11-19 09:00AM | CohBar Announces the Appointment of Dr. Phyllis Gardner to its Board of Directors GlobeNewswire |
| Feb-05-19 08:15AM | Allergan Stock Falls as FDA OK's Botox Rival for Frown Lines Zacks |
| Jan-28-19 07:23AM | What Kind Of Shareholders Own Revance Therapeutics, Inc. (NASDAQ:RVNC)? Simply Wall St. |
| Jan-25-19 07:30AM | Investor Expectations to Drive Momentum within International Paper, Gray Television, Nielsen Holdings Plc, e.l.f. Beauty, NIC, and Revance Therapeutics Discovering Underlying Factors of Influence GlobeNewswire |
| Jan-22-19 04:05PM | Revance Announces Closing of Public Offering of Common Stock Business Wire |
| Jan-17-19 06:50AM | Revance Announces Pricing of Public Offering of Common Stock Business Wire |
| Jan-16-19 08:24AM | The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen Benzinga -10.28% |
| Jan-15-19 04:17PM | Revance Announces Proposed Public Offering of Common Stock Business Wire |
| 08:05AM | Revance Announces Ground-Breaking Data Presentations at Leading International Neurotoxin Conference Business Wire |
| Jan-07-19 08:05AM | Revance Highlights Recent Regulatory Progress and Provides Anticipated 2019 Milestones Business Wire |
| Dec-05-18 06:50AM | Today's Research Reports on Trending Tickers: Novelion Therapeutics and Revance Therapeutics ACCESSWIRE |
| Dec-04-18 02:08PM | Revance Therapeutics reaches licensing agreement with Fosun Pharmaceutical over botox formulation RT002 MarketWatch +19.47% |
| 11:12AM | Revance Therapeutics' Botox rival succeeds in late-stage trial Reuters |
| 08:27AM | Revance Therapeutics' frown lines treatment succeeds in late-stage trial Reuters |
| 08:06AM | Revance Announces China Market License Agreement with Fosun Pharma for RT002 Business Wire |
| 08:05AM | Revances RT002 Demonstrates Unprecedented Efficacy and Duration In Largest-Ever Aesthetic Neuromodulator Clinical Program Business Wire |
| Nov-27-18 07:40AM | Market Trends Toward New Normal in Palatin Technologies, Revance Therapeutics, Geo Group, QUANTENNA COMMS, The Navigators Group, and INVESCO MORTGAGE CAPITAL INC Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| Nov-20-18 04:05PM | Revance to Participate in Upcoming Investor Conferences Business Wire |
| Nov-16-18 03:48PM | Edited Transcript of RVNC earnings conference call or presentation 1-Nov-18 8:30pm GMT Thomson Reuters StreetEvents |
| Nov-15-18 12:20PM | Why Revance Therapeutics Incs (NASDAQ:RVNC) CEO Pay Matters To You Simply Wall St. |
| Nov-07-18 04:05PM | Revance to Participate in the Credit Suisse Healthcare Conference Business Wire |
| Nov-01-18 04:05PM | Revance Releases Third Quarter 2018 Results Business Wire +5.70% |
| Oct-18-18 04:05PM | Revance Therapeutics to Release Third Quarter 2018 Financial Results on Thursday, November 1, 2018 Business Wire |
| Oct-11-18 09:00AM | Investor Expectations to Drive Momentum within Materion, Iridium Communications, Natural Health Trends, Revance Therapeutics, Baxter International, and Alexion Pharmaceuticals Discovering Underlying Factors of Influence GlobeNewswire |
| 08:30AM | Revance Therapeutics Appoints Tobin C. Schilke as Chief Financial Officer Business Wire |
| Sep-24-18 04:05PM | Revance to Participate in the Cantor Fitzgerald 2018 Global Healthcare Conference Business Wire |
| Sep-20-18 04:24PM | Revance Receives Great Place to Work Certification Business Wire |
| 01:42PM | Before You Buy Revance Therapeutics Incs (NASDAQ:RVNC), Consider This Simply Wall St. |
| Sep-17-18 04:11PM | JMP: Changing Competitive Landscape Makes Revance Less Appealing Benzinga -8.28% |
| Sep-14-18 11:34AM | Allergan says revenue from aesthetics unit may double by 2025 Reuters |
| Aug-07-18 07:30AM | New Research Coverage Highlights Titan International, Revance Therapeutics, Ryerson Holding, Iridium Communications, Chase, and Peoples Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire |
| Aug-03-18 11:19AM | Edited Transcript of RVNC earnings conference call or presentation 2-Aug-18 8:30pm GMT Thomson Reuters StreetEvents -9.75% |
| Aug-02-18 04:05PM | Revance Releases Second Quarter 2018 Results Business Wire |
| 02:30PM | Revance Therapeutics, Inc. to Host Earnings Call ACCESSWIRE |
| Jul-19-18 04:05PM | Revance Therapeutics to Release Second Quarter 2018 Financial Results on Thursday, August 2, 2018 Business Wire |
| Jul-17-18 07:19AM | Revance Therapeutics Sees Hammer Chart Pattern: Time to Buy? Zacks |
| Jul-10-18 06:33PM | Cramer: Don't get your hopes up with the stock of Botox maker Allergan CNBC |
| Jun-21-18 04:05PM | Revance Doses First Patient in ASPEN Phase 3 Clinical Program of RT002 Injectable for the Treatment of Cervical Dystonia Business Wire |
| Jun-20-18 12:02PM | Top Growth Stocks in June Simply Wall St. |
| Jun-14-18 04:05PM | Revance to Participate in the JMP Securities Life Sciences Conference 2018 Business Wire |
| Jun-05-18 04:05PM | Revance to Participate in Upcoming Investor Conferences Business Wire |
| May-29-18 04:05PM | Revance to Participate in the Jefferies 2018 Global Healthcare Conference Business Wire -10.19% |
| 07:00AM | Revance Announces Departure of Chief Financial Officer Business Wire |
| May-24-18 04:05PM | Revance Announces Publication of Positive 24-Week Duration of Effect Results from Cervical Dystonia Phase 2 Trial in Movement Disorders Clinical Practice Business Wire |
| May-18-18 12:02PM | High Growth NasdaqCM Stocks For The Day Simply Wall St. |
| May-17-18 04:18PM | Allergan's Meury Talks Market Expansion in Aesthetics TheStreet.com |
| May-15-18 04:05PM | Revance to Participate in the UBS Global Healthcare Conference Business Wire |
| May-10-18 03:46AM | Edited Transcript of RVNC earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents |
| May-09-18 04:05PM | Revance Therapeutics Announces Two Recent Additions to Its Management Team Business Wire |
| May-08-18 04:05PM | Revance Releases First Quarter 2018 Results Business Wire |
| May-02-18 07:50AM | Factors of Influence in 2018, Key Indicators and Opportunity within Independent Bank Group, Eclipse Resources, Stellus Capital Investment, International Bancshares, Portola Pharmaceuticals, and Revance Therapeutics New Research Emphasizes Economic Growth GlobeNewswire |
| May-01-18 04:05PM | Revance Therapeutics Expands Leadership Team, Appointing Caryn McDowell as SVP, General Counsel & Corporate Secretary CNBC |
| 04:05PM | Revance Therapeutics Expands Leadership Team, Appointing Caryn McDowell as SVP, General Counsel & Corporate Secretary Business Wire |
| Apr-30-18 03:25PM | Revance Therapeutics Took the Least Resistance Path, Turned Lower TheStreet.com |
| Apr-25-18 04:05PM | Pivotal SAKURA Phase 3 Clinical Data to be Featured in Oral and Poster Presentations at The Aesthetic Meeting 2018 Business Wire |
| Apr-24-18 04:05PM | Revance Therapeutics to Release First Quarter 2018 Financial Results on Tuesday, May 8, 2018 Business Wire |
| Apr-23-18 12:22PM | Rival Botox Maker Says Patients Can't Wait for It to Hit Bloomberg |
| Apr-19-18 12:52PM | CEO of Botox competitor: 'With scale,' we think we'll hav... CNBC Videos |
| 11:30AM | Revance Investor Day Highlights New Neuroscience Indications in Development Business Wire |
| 09:24AM | Revance Therapeutics Stock Looks Ready for New Gains TheStreet.com |
| Apr-18-18 08:25PM | Revance Therapeutics: Cramer's Top Takeaways TheStreet.com |
| 07:01PM | Cramer Remix: Wall Streets big problem with IBMs stock CNBC Videos |
| Apr-02-18 04:05PM | Revance Therapeutics Expands Commercialization Team to Gear Up for Product Launch of RT002 Injectable Business Wire |
| Mar-26-18 04:05PM | Revance to Host Investor Day on April 19, 2018 Business Wire |
| Mar-21-18 07:10AM | Edited Transcript of RVNC earnings conference call or presentation 28-Feb-18 9:30pm GMT Thomson Reuters StreetEvents |
| Mar-20-18 04:05PM | Revance to Participate in the Needham Healthcare Conference Business Wire |
| Mar-13-18 04:32PM | Cantor Fitzgerald Names 8 Upcoming Biotech Catalysts Benzinga |
| Mar-06-18 04:05PM | Revance to Participate in Upcoming Investor Conferences Business Wire |
| Mar-05-18 03:30PM | Goldman Sachs Sees 100% Upside In This Biopharma Company Benzinga |
| Mar-04-18 12:37PM | Mylan shares bounce on plans for Botox copycat, 2018 drug launches MarketWatch |
| 11:33AM | Here's Why Allergan plc Stock Tanked 14.4% in February Motley Fool |
| Mar-02-18 06:48PM | Revance Therapeutics Inc (RVNC) Files 10-K for the Fiscal Year Ended on December 31, 2017 GuruFocus.com |
| 11:55AM | Mylan shares bounce on plans for Botox copycat, 2018 drug launches MarketWatch |
| Mar-01-18 05:30PM | Pressure May Be On Allergan to Strike a Major Deal, As Botox Gets Another Rival TheStreet.com |
| 05:06PM | Allergan Tanks To 5-Year Low As Botox Rivalry Heats With Mylan Investor's Business Daily |
| 10:16AM | Mylan Shares Jump After Earnings Beat TheStreet.com |
| Feb-28-18 05:57PM | Revance reports 4Q loss Associated Press |
| 05:36PM | Mylan teams up with Revance on biosimilar for Botox Reuters |
| 04:44PM | Mylan Reports Light Fourth-Quarter Sales But Profit Tops; Guidance Mixed Investor's Business Daily |
